Relaxation Dynamics and Crystallization Study of Sildenafil in the Liquid and Glassy States
Overview
Affiliations
In this paper, the physical stability and molecular dynamics of amorphous sildenafil are investigated in both the liquid and glassy states. We have established that the amorphous sildenafil is resistant to recrystallization at temperatures below the glass transition temperature Tg during the experimental period of its storage (i.e., above 6 months), however, it easily undergoes cold crystallization at T > Tg. To determine the crystallization mechanism, the isothermal and non-isothermal studies of the cold crystallization kinetics of the drug are performed by using the broadband dielectric spectroscopy (BDS) and the differential scanning calorimetry (DSC), respectively. The cold crystallization mechanism has been found to be similar in both the isothermal and non-isothermal cases. This mechanism has been analyzed from the point of view of the molecular mobility of sildenafil investigated in the supercooled liquid and glassy states by using the BDS measurements in the wide temperature range. This analysis has been enriched with a new approach based on a recently reported measure of dynamic heterogeneity given by a four-point dynamic susceptibility function. No tendency to recrystallization of glassy sildenafil at T < Tg is also discussed in relation to molecular dynamics of sildenafil in the glassy state. The relatively small molecular mobility reflected in one secondary relaxation as well as the predicted large time scale of structural relaxation of glassy sildenafil suggests that amorphous sildenafil should not recrystallize during its long-term storage at room temperature.
Tuning the Physical State of Aripiprazole by Mesoporous Silica.
Kramarczyk D, Knapik-Kowalczuk J, Klimontko J, Kurek M, Jachowicz R, Paluch M Mol Pharm. 2024; 21(5):2315-2326.
PMID: 38644570 PMC: 11080047. DOI: 10.1021/acs.molpharmaceut.3c01095.
Fragility and Tendency to Crystallization for Structurally Related Compounds.
Grzybowska K, Wojnarowska Z, Grzybowski A, Paluch M Int J Mol Sci. 2024; 25(6).
PMID: 38542174 PMC: 10969839. DOI: 10.3390/ijms25063200.
Grzybowska K, Rams-Baron M, Lucak K, Grzybowski A, Paluch M Int J Mol Sci. 2022; 23(17).
PMID: 36077212 PMC: 9456116. DOI: 10.3390/ijms23179794.
The Effect of Various Poly (-vinylpyrrolidone) (PVP) Polymers on the Crystallization of Flutamide.
Heczko D, Hachula B, Maksym P, Kaminski K, Zieba A, Orszulak L Pharmaceuticals (Basel). 2022; 15(8).
PMID: 36015118 PMC: 9414356. DOI: 10.3390/ph15080971.
Valenti S, Del Valle L, Romanini M, Mitjana M, Puiggali J, Tamarit J Int J Mol Sci. 2022; 23(5).
PMID: 35269593 PMC: 8910109. DOI: 10.3390/ijms23052456.